In NSCLC cells, cisplatin, adriamycin or GEM induces COX2 expression, which in turn inhibits drug-induced cell apoptosis by activating the anti-apoptotic protein BCL2 [139]. Here, PTGS2 is linked to non-small cell lung carcinoma.